Q4 2018 Sunesis Pharmaceuticals Inc Earnings Call Transcript
Welcome to Sunesis Pharmaceuticals Fourth Quarter and Year-End 2018 Earnings Conference Call. (Operator Instructions) As a reminder, today's conference is being recorded.
I would now like to turn the conference over to Willie Quinn, Chief Financial Officer and Senior Vice President, Corporate Development. Please go ahead.
Thank you. Thank you all for joining us. With me today are Dayton Misfeldt, Interim Chief Executive Officer; Judy Fox, Chief Scientific Officer; Par Hyare, Vice President, Global Oncology Operations; and Deepali Suri, Vice President, Clinical Operations.
Dayton will review recent corporate events, and I will provide a brief overview of fourth quarter and year-end 2018 financial results. We will then open the call for questions, for which Judy, Par and Deepali will also be available.
Before we begin, let me remind you that during today's conference call, we will be making forward-looking statements that
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |